Ethylene

Ethylene

SCHEMBL6991436

C=C.CCOC(C)OCC.O=C1CN(CCCN2CCC(c3ccccc3)CC2)S(=O)(=O)c2ccccc21

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.42
DRD2 P14416 2/20 0.40
SLC18A3 Q16572 2/20 0.39
CTDSP1 Q9GZU7 1/20 0.39
PRCP P42785 2/20 0.39
OPRM1 P35372 1/20 0.38
SIGMAR1 Q99720 3/20 0.38
CHRM2 P08172 1/20 0.38
CHRM4 P08173 1/20 0.38
CHRM5 P08912 1/20 0.38
CHRM1 P11229 1/20 0.38
CHRM3 P20309 1/20 0.38
DRD4 P21917 1/20 0.38
DRD3 P35462 1/20 0.38
MEN1 O00255 1/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL6999262 0.86 DRD2 (0.51) TDP1DRD2CTDSP1DRD4DRD3
Ethylene SCHEMBL6997933 0.85 DRD2 (0.46) TDP1DRD2CTDSP1OPRM1CHRM2
Ethylene SCHEMBL6995806 0.82 DRD2 (0.45) TDP1DRD2CTDSP1DRD4DRD3
Ethylene SCHEMBL7104272 0.82 HTR1A (0.55) TDP1DRD2DRD4DRD3CYP1A2
Ethylene SCHEMBL6996408 0.81 TDP1 (0.50) TDP1CTDSP1MEN1KMT2A
Ethylene SCHEMBL6995999 0.81 DRD2 (0.45) TDP1DRD2SIGMAR1DRD4DRD3
Ethylene SCHEMBL7001820 0.81 DRD2 (0.53) TDP1DRD2DRD4DRD3
Ethylene SCHEMBL6994585 0.81 DRD2 (0.54) TDP1DRD2SIGMAR1DRD4DRD3
Ethylene SCHEMBL6996278 0.81 HTR1A (0.46) TDP1DRD2DRD4DRD3
Ethylene SCHEMBL6998096 0.81 ADRA1D (0.38) DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6664251-B2 Serotonin receptor antagonist; treating cardiovascular disorder DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2003-12-16 US disclosed
EP-0686632-B1 BENZOTHIAZINE DERIVATIVE DAIICHI SUNTORY PHARMA CO LTD (JP) 2003-08-06 EP disclosed
US-20030078256-A1 Benzothiazine derivative SUNTORY LIMITED (JP) 2003-04-24 US disclosed
US-6316442-B1 TREATMENT OF HEART DISEASE AND CEREBROVASCULAR DISTURBANCES SUNTORY LIMITED (JP) 2001-11-13 US disclosed
US-6001827-A Benzothiazine derivative SUNTORY LIMITED (JP) 1999-12-14 US disclosed
US-5874429-A ANTIISCHEMIC AGENTS; CEREBROVASCULAR DISORDERS; CIRCULATORY IDSORDERS SUNTORY LIMITED (JP) 1999-02-23 US disclosed
EP-0686632-A1 BENZOTHIAZINE DERIVATIVE SUNTORY LIMITED (JP) 1995-12-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078256-A1 Benzothiazine derivative TPH2, ADRB2, TPH1 TDP1 3378/4885DRD2 402/4885SLC18A3 3461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.